Pharmacogenomics and pharmacokinetics study of drug metabolizing enzyme in patients with severe adverse drug reaction due to anti-neoplastics
Not Applicable
- Conditions
- Cancer
- Registration Number
- JPRN-UMIN000002339
- Lead Sponsor
- Graduate Schhol of Medicine Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Informed consent not obtained
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Genetic polymorphism drug or metabolite concentration
- Secondary Outcome Measures
Name Time Method